enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Fabry disease - Wikipedia

    en.wikipedia.org/wiki/Fabry_disease

    Fabry disease, also known as Anderson–Fabry disease, is a rare genetic disease that can affect many parts of the body, including the kidneys, heart, brain, and skin. [1] Fabry disease is one of a group of conditions known as lysosomal storage diseases .

  3. GLA (gene) - Wikipedia

    en.wikipedia.org/wiki/GLA_(gene)

    This disease may have late onset and only affect the heart or kidneys. [8] Fabry disease is an X-linked disease, affecting 1 in 40,000 males. However, unlike other X-linked diseases, this condition also creates significant medical problems for females carrying only 1 copy of the defective GLA gene.

  4. List of OMIM disorder codes - Wikipedia

    en.wikipedia.org/wiki/List_of_OMIM_disorder_codes

    This is a list of disorder codes in the Online Mendelian Inheritance in Man (OMIM) database. These are diseases that can be inherited via a Mendelian genetic mechanism. OMIM is one of the databases housed in the U.S. National Center for Biotechnology Information.

  5. Sangamo's Fabry Disease Gene Therapy Continues To Show ... - AOL

    www.aol.com/news/sangamos-fabry-disease-gene...

    Sangamo Therapeutics Inc (NASDAQ: SGMO) has announced updated preliminary results from the Phase 1/2 STAAR study of isaralgagene civaparvovec, or ST-920, a gene therapy candidate for Fabry disease.

  6. List of genetic disorders - Wikipedia

    en.wikipedia.org/wiki/List_of_genetic_disorders

    The following is a list of genetic disorders and if known, type of mutation and for the chromosome involved. Although the parlance "disease-causing gene" is common, it is the occurrence of an abnormality in the parents that causes the impairment to develop within the child. There are over 6,000 known genetic disorders in humans.

  7. Avrobio Plans Registration Trial With Kidney Biopsy Endpoint ...

    www.aol.com/news/avrobio-plans-registration...

    Avrobio Inc (NASDAQ: AVRO) has provided an update on its regulatory plans for AVR-RD-01, its lentiviral gene therapy for Fabry disease, currently in FAB-GT Phase 2 trial. In March, the FDA granted ...

  8. Sphingolipidoses - Wikipedia

    en.wikipedia.org/wiki/Sphingolipidoses

    Enzyme replacement therapy is available to treat mainly Fabry disease and Gaucher disease, and people with these types of sphingolipidoses may live well into adulthood. The other types are generally fatal by age 1 to 5 years for infantile forms, but progression may be mild for juvenile- or adult-onset forms.

  9. α-Galactosidase - Wikipedia

    en.wikipedia.org/wiki/Α-Galactosidase

    α-Galactosidase ( EC 3.2.1.22, α-GAL, α-GAL A; systematic name α-D-galactoside galactohydrolase) is a glycoside hydrolase enzyme that catalyses the following reaction: [1]